Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × alvimopan × Clear all

Phase

Phase 3 3 Phase 2 1

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1 Ileus 1

Interventions

Cisplatin 889 Cyclophosphamide 840 Carboplatin 834 Radiotherapy 780 Bevacizumab 737 Gemcitabine 708 pembrolizumab 657 Docetaxel 653 Paclitaxel 645 Oxaliplatin 610 Capecitabine 569 Fluorouracil 512 Rituximab 498 Nivolumab 438 Dexamethasone 432 Etoposide 409 Doxorubicin 398 Irinotecan 392 Leucovorin 338 Drug Therapy 336 Cytarabine 301 Cetuximab 295 Lenalidomide 288 Trastuzumab 281 Pemetrexed 279 durvalumab 262 Filgrastim 250 Magnetic Resonance Spectroscopy 239 Prednisone 237 Temozolomide 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03352414 2021-08-18

ILEUS

University of California, San Diego

Phase 2 Terminated

84 enrolled 10 charts

Peritoneal Neoplasms, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡